Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.
about
Triple reuptake inhibitors: the next generation of antidepressantsTriple Reuptake Inhibitors: A Premise and PromiseA comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.Comparative efficacy of escitalopram in the treatment of major depressive disorder.The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments.Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.The hidden third: improving outcome in treatment-resistant depression.Current treatment options: relief of symptoms and ultimate recovery.Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study.
P2860
Q24658248-4EC30EF2-919D-4808-B466-161C7F527BAEQ28972234-0AB7F485-2D72-475F-85F2-81AA656FABA4Q33718185-6D16E987-EC6E-4EA0-9750-E701173A9B28Q34072466-16F63223-257E-423F-B109-15D03E3FC004Q34355963-C12798D8-5196-4F13-AA37-2671808E2A59Q34664591-33B6796C-E868-41FA-A40A-13FA22A6D739Q36960563-8CB6146B-3C20-4D18-B59E-3E8DDDF7A012Q37424333-05BAA3D4-CC26-45B2-96A3-A12EB806D9C8Q37709437-2D8B44C4-81D9-4477-A08A-AC225FCF3600Q37928965-A41C36BB-774E-49F6-B2F6-55A8F1E99D9CQ37974998-A0AE210A-8E89-4848-B810-7774D0684E3DQ39357187-FDA1D9AE-EB84-41C4-99B7-E8F8163E7DF9Q48890531-6E9EBC31-A500-4600-871F-D1BB1119F5F2Q51853676-26B5D572-25DA-4BA6-950A-0E300DBB1FB6
P2860
Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Onset of action of escitalopra ...... results of a pooled analysis.
@en
Onset of action of escitalopra ...... results of a pooled analysis.
@nl
type
label
Onset of action of escitalopra ...... results of a pooled analysis.
@en
Onset of action of escitalopra ...... results of a pooled analysis.
@nl
prefLabel
Onset of action of escitalopra ...... results of a pooled analysis.
@en
Onset of action of escitalopra ...... results of a pooled analysis.
@nl
P2093
P1476
Onset of action of escitalopra ...... results of a pooled analysis.
@en
P2093
Christian Spadone
Jules Angst
Patrice Verpillat
P304
P356
10.1097/01.YIC.0000194375.42589.C3
P577
2006-03-01T00:00:00Z